SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-017875
Filing Date
2023-05-04
Accepted
2023-05-04 16:16:08
Documents
62
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tyra-20230331.htm   iXBRL 10-Q 1532356
2 EX-31.1 tyra-ex31_1.htm EX-31 21228
3 EX-31.2 tyra-ex31_2.htm EX-31 21458
4 EX-32.1 tyra-ex32_1.htm EX-32 11831
5 EX-32.2 tyra-ex32_2.htm EX-32 11794
  Complete submission text file 0000950170-23-017875.txt   6425651

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tyra-20230331_cal.xml EX-101.CAL 33283
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tyra-20230331_def.xml EX-101.DEF 180388
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tyra-20230331.xsd EX-101.SCH 52553
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tyra-20230331_lab.xml EX-101.LAB 412153
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tyra-20230331_pre.xml EX-101.PRE 310587
56 EXTRACTED XBRL INSTANCE DOCUMENT tyra-20230331_htm.xml XML 1161586
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

IRS No.: 831476348 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40800 | Film No.: 23888968
SIC: 2834 Pharmaceutical Preparations